lung image

Respiratory

This online medical resource contains scientific respiratory information from GSK. It is focused on disease education and is intended for UK healthcare professionals only.

Search Tool

Please provide the search terms and press enter

    Min 1 keyword(s) is required

    Recently Searched Keywords

    Respiratory

    Respiratory (2)

    Format (5)

      13 Results

      COPD

      Our website is dedicated to providing you with the highest quality of scientific information related to COPD

      Infographics
      Recognising COPD Exacerbations Infographic
      Recognising COPD Exacerbations Infographic
      Recognising COPD Exacerbations Infographic

      Long-Term damaging effects and risk factors

      SEE NOW
      Congress poster
      ATS Multivariable Prediction of Exacerbations in a COPD Population: A Prospective Analysis
      ATS Multivariable Prediction of Exacerbations in a COPD Population: A Prospective Analysis
      ATS Multivariable Prediction of Exacerbations in a COPD Population: A Prospective Analysis

      NX-GB-CPU-PSTR-240002 August 2024. This GSK funded poster presented at ATS 2024 may be of interest, by Jones PW et al

      SEE NOW
      Congress poster
      ATS Data-driven Identification and Investigation of Comorbidity Profiles in Patients with COPD: A Multicohort Study
      ATS Data-driven Identification and Investigation of Comorbidity Profiles in Patients with COPD: A Multicohort Study
      ATS Data-driven Identification and Investigation of Comorbidity Profiles in Patients with COPD: A Multicohort Study

      NX-GB-CPU-PPT-240002 August 2024. This GSK fudned poster presented at ATS 2024 may be of interest, by L. Egerod et al

      SEE NOW
      Medical Education
      What is COPD?
      What is COPD?
      What is COPD?

      Explore the fundamentals of COPD

      SEE NOW
      Medical Education
      Assessment
      Assessment
      Assessment

      Multiple Choice Questions

      SEE NOW
      Congress poster
      ATS Leveraging Machine Learning and Real World data to Predict COPD Exacerbations
      ATS Leveraging Machine Learning and Real World data to Predict COPD Exacerbations
      ATS Leveraging Machine Learning and Real World data to Predict COPD Exacerbations

      NX-GB-CPU-PSTR-240001 August 2024. This GSK funded poster presented at ATS 2024 may be of interest, by Panettieri R et al

      SEE NOW
      Medical Education
      Recognising COPD Exacerbations
      Recognising COPD Exacerbations
      Recognising COPD Exacerbations

      Long-Term damaging effects and risk factors

      SEE NOW
      Medical Education
      The prevalence and burden of COPD
      The prevalence and burden of COPD
      The prevalence and burden of COPD

      Explore the prevalence and attributable health burden of COPD

      SEE NOW
      Video
      8.37 min
      Enough is enough: the true burden of COPD
      Enough is enough: the true burden of COPD
      Enough is enough: the true burden of COPD

      Understand why an umbrella approach is not appropriate for managing these complex diseases

      SEE NOW

      Treatable Traits in Obstructive Airways Disease

      Our website is dedicated to providing you with the highest quality of scientific information related to the role of Treatable Traits in airways disease

      Podcast
      20.11 min
      How did the Treatable Traits approach develop?
      How did the Treatable Traits approach develop?
      How did the Treatable Traits approach develop?

      Background contextual information to the Treatable Traits approach, including the transition from a phenotype based approach

      SEE NOW
      Video
      7.44 min
      Why use Treatable Traits in airways disease?
      Why use Treatable Traits in airways disease?
      Why use Treatable Traits in airways disease?

      Introduction to the Treatable Traits approach and rationale for why it is a robust strategy for the management of airways diseases

      SEE NOW
      Medical Education
      Can Treatable Traits map a more direct route towards optimal treatment?
      Can Treatable Traits map a more direct route towards optimal treatment?
      Can Treatable Traits map a more direct route towards optimal treatment?

      An overview of the Treatable Traits approach, how this approach may benefit patients and be implemented in primary care

      SEE NOW
      Medical Education
      Hitting the target: The evidence behind management of Treatable Traits
      Hitting the target: The evidence behind management of Treatable Traits
      Hitting the target: The evidence behind management of Treatable Traits

      Presentation covering examples of Treatable Traits and eosinophilic airway inflammation, COPD clinical data; Prime Treatable Traits examples

      SEE NOW

      September 2024 | NX-GB-RS-WCNT-240001 (V2.0)

      Open cookie banner
      Hide cookie banner